# Evaluation of STARgraft-3 for Hemodialysis

> **NCT05729620** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Healionics Corporation** · enrollment: 21 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Implant of STARgraft-3 shunt in the upper arm and subsequent use for hemodialysis access

## Key facts

- **NCT ID:** NCT05729620
- **Lead sponsor:** Healionics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-29
- **Primary completion:** 2024-02-02
- **Final completion:** 2027-07
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05729620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05729620, "Evaluation of STARgraft-3 for Hemodialysis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05729620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*